Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 5/20 | 0.86 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.61 |
| ▸ | ALPI | P09923 | 1/20 | 0.61 |
| ▸ | PKM | P14618 | 1/20 | 0.61 |
| ▸ | XIAP | P98170 | 1/20 | 0.61 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.57 |
| ▸ | USP2 | O75604 | 1/20 | 0.57 |
| ▸ | EGFR | P00533 | 1/20 | 0.57 |
| ▸ | LCK | P06239 | 1/20 | 0.57 |
| ▸ | FYN | P06241 | 1/20 | 0.57 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.57 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.57 |
| ▸ | HTR2A | P28223 | 1/20 | 0.57 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.57 |
| ▸ | RECQL | P46063 | 1/20 | 0.57 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.57 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.57 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.57 |
| ▸ | PCNA | P12004 | 1/20 | 0.55 |
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.53 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tyrosine SCHEMBL1356957 | 1.00 | SLC7A5 (0.86) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL7413965 | 0.97 | SLC7A5 (0.80) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL22390812 | 0.95 | SLC7A5 (0.77) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL28297995 | 0.93 | SLC7A5 (0.92) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL5222909 | 0.93 | SLC7A5 (0.92) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL28270669 | 0.93 | SLC7A5 (0.92) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL6374042 | 0.93 | SLC7A5 (0.92) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL10978820 | 0.93 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL11676395 | 0.93 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP | |
| Tyrosine SCHEMBL1581 | 0.93 | SLC7A5 (1.00) | SLC7A5PTGS1ALPIPKMXIAP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005826-B2 | Compounds that bind to the erythropoietin receptor | EPODOSE LLC (US) | 2018-06-26 | — | — | US | disclosed |
| US-20170029481-A1 | Compounds That Bind to the Erythropoietin Receptor | EPODOSE LLC (US) | 2017-02-02 | — | — | US | disclosed |
| US-9422338-B2 | Compounds that bind to the erythropoietin receptor | EPODOSE LLC (US) | 2016-08-23 | — | — | US | disclosed |
| US-20150038403-A1 | Compounds That Bind to the Erythropoietin Receptor | EPODOSE LLC | 2015-02-05 | — | — | US | disclosed |
| EP-2709648-A2 | COMPOUNDS THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | Geysen, Hendrik, Mario (US) | 2014-03-26 | — | — | EP | disclosed |
| US-20130012685-A1 | NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | AFFYMAX, INC. (US) | 2013-01-10 | — | — | US | disclosed |
| WO-2012158493-A2 | COMPOUNDS THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | GEYSEN HENDRIK M (US) | 2012-11-22 | — | — | WO | disclosed |
| US-8313936-B2 | Nucleic acids and polypeptides involved in the production of cryptophycin | REGENTS OF THE UNIVERSITY OF MICHIGAN (US) | 2012-11-20 | — | — | US | disclosed |
| US-20120220008-A1 | NUCLEIC ACIDS AND POLYPEPTIDES INVOLVED IN THE PRODUCTION OF CRYPTOPHYCIN | REGENTS OF THE UNIVERSITY OF MICHIGAN | 2012-08-30 | — | — | US | disclosed |
| US-20120157660-A1 | NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | AFFYMAX, INC. (US) | 2012-06-21 | — | — | US | disclosed |
| WO-2001068039-A2 | HAIR CARE COMPOSITION CONTAINING A POLYALKYLENEGLYCOL(n)ALKYLAMINE | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-20 | — | — | WO | disclosed |
| WO-2001068051-A1 | HAIR CARE COMPOSITION CONTAINING POLYALKYLENEGLYCOL(n)ALKYLAMINE AND ORGANIC ACID | THE PROCTER & GAMBLE COMPANY (US) | 2001-09-20 | — | — | WO | disclosed |
| EP-1133522-A1 | ANTAGONISTIC ANALOGS OF GH-RH INHIBITING IGF-I AND -II | The Administrators of The Tulane Educational Fund (US) | 2001-09-19 | — | — | EP | disclosed |
| WO-2001058930-A1 | PAR4 PEPTIDES AND POLYPEPTIDES | ZYMOGENETICS, INC. (US) | 2001-08-16 | — | — | WO | disclosed |
| WO-2000031136-A9 | ANTAGONISTIC ANALOGS OF GH-RH INHIBITING IGF-I AND -II | UNIV TULANE (US) | 2001-07-19 | — | — | WO | disclosed |
| WO-2000031136-A1 | ANTAGONISTIC ANALOGS OF GH-RH INHIBITING IGF-I AND -II | ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2000-06-02 | — | — | WO | disclosed |
| US-6057422-A | AMINO ACID SEQUENCE OF SYNTHETIC POLYPEPTIDE OF HUMAN GROWTH HORMONE-RELEASING HORMONE WHICH SUPPRESSES RELEASE OF INSULIN-LIKE GROWTH FACTORS; FOR ANTICARCINOGENIC AGENTS | THE ADMINISTRATORS OF THE TULANE EDUCATIONAL FUND (US) | 2000-05-02 | — | — | US | disclosed |
| US-5962407-A | CYCLIC DECAPEPTIDES ARE ACTIVE AGAINST BOTH GRAM POSITIVE AND GRAM NEGATIVE BACTERIA. | SEATEK MARINE BIOTECHNOLOGY, INC. | 1999-10-05 | — | — | US | disclosed |
| WO-1998004584-A1 | CYCLIC DECAPEPTIDE ANTIBIOTICS | SEATEK MARINE BIOTECHNOLOGY, INC. (CA) | 1998-02-05 | — | — | WO | disclosed |
| US-4695588-A | DECARBOXYLASE INHIBITORS | MERCK & CO., INC. (US) | 1987-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130012685-A1 | NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | EPOR, PROKR1, EDNRB | SLC7A5 2604/4885PTGS1 3169/4885ALPI 4211/4885 |
| US-10005826-B2 | Compounds that bind to the erythropoietin receptor | EPOR, EDNRB, EDNRA | SLC7A5 3242/4885PTGS1 2502/4885ALPI 3256/4885 |
| US-20150038403-A1 | Compounds That Bind to the Erythropoietin Receptor | EPOR, EDNRB, EDNRA | SLC7A5 3242/4885PTGS1 2502/4885ALPI 3256/4885 |
| US-20120157660-A1 | NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | EPOR, PROKR1, EDNRB | SLC7A5 2604/4885PTGS1 3169/4885ALPI 4211/4885 |
| US-20170029481-A1 | Compounds That Bind to the Erythropoietin Receptor | EPOR, EDNRB, EDNRA | SLC7A5 3242/4885PTGS1 2502/4885ALPI 3256/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.